We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Frontage Receives Approval for Manufacture of Schedule I and II Drug Products

News   Dec 24, 2013

 
Frontage Receives Approval for Manufacture of Schedule I and II Drug Products
 
 
 

RELATED ARTICLES

Team Design Drug Molecule to Improve Heart Attack Recovery

News

A new molecule has been developed that could help preserve heart tissue during – and even after – a heart attack.

READ MORE

Prescription Omega-3 Fatty Acid Meds Lower High Triglycerides by 20–30%

News

Prescription omega-3 fatty acid medication reduces triglyceride levels by 20-30% among the majority of people who require treatment for high triglyceride levels, according to a science advisory from the American Heart Association.

READ MORE

Study Suggests a Lack of Racial Diversity in Cancer Drug Trials

News

A new study has found that fewer than 8% of cancer drug trials reported participation from the four major races in the United States – white, Asian, black and Hispanic – between 2008 and 2018.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE